Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  T2 Biosystems Inc    TTOO

T2 BIOSYSTEMS INC

(TTOO)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/10/2019 09/11/2019 09/12/2019 09/13/2019 09/16/2019 Date
1.43(c) 2.61(c) 3.01(c) 2.88(c) 2.7799 Last
1 401 741 16 596 294 13 629 876 4 507 509 915 216 Volume
-2.72% +82.52% +15.33% -4.32% -3.48% Change
More quotes
Financials (USD)
Sales 2019 10,2 M
EBIT 2019 -50,3 M
Net income 2019 -56,5 M
Debt 2019 -
Yield 2019 -
Sales 2020 22,2 M
EBIT 2020 -37,6 M
Net income 2020 -41,6 M
Debt 2020 -
Yield 2020 -
P/E ratio 2019 -2,43x
P/E ratio 2020 -3,78x
Capi. / Sales2019 12,7x
Capi. / Sales2020 5,84x
Capitalization 129 M
More Financials
Company
T2 Biosystems, Inc. is an in vitro diagnostics company engaged in developing a technology platform offering an alternative to diagnostic methodologies. The Company's T2 Magnetic Resonance platform (T2MR) enables detection of pathogens, biomarkers and other abnormalities in a range of unpurified... 
More about the company
Surperformance© ratings of T2 Biosystems Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on T2 BIOSYSTEMS INC
09/11T2 Biosystems Receives Funding from BARDA to Advance Technology for Diagnosis..
GL
09/10T2 Biosystems to Host Conference Call to Discuss Awarding of Multi-Million Do..
GL
09/10T2 Biosystems Announces Restructuring of CRG Term Loan Agreement
GL
09/10T2 Biosystems Awarded Breakthrough Technology Contract with Premier Inc.
GL
09/10T2 BIOSYSTEMS, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
08/29T2 Biosystems to Present at the Janney Healthcare Conference 2019
GL
08/16T2 Biosystems Expands Access to its Innovative Rapid Diagnostic Technologies ..
GL
08/14T2 Biosystems Reports Granting of Inducement Awards
GL
08/06T2 BIOSYSTEMS : T2Bacteria Panel is the First and Only In-Vitro Diagnostic Test ..
PU
08/06T2Bacteria Panel is the First and Only In-Vitro Diagnostic Test to Receive Ap..
GL
More news
Analyst Recommendations on T2 BIOSYSTEMS INC
More recommendations
Sector news : Medical Equipment, Supplies & Distribution - NEC
01:50aSANOFI : Abbott to Collaborate on Glucose Sensing, Insulin Delivery Data
DJ
09/14Companies ask judge in U.S. opioid trial to recuse himself
RE
09/10BAXTER INTERNATIONAL : to Buy Cheetah Medical for Up to $230 Million
DJ
09/04GLOBAL MARKETS LIVE : Boeing, Bayer, Purdue, KBC…
09/04STRYKER : to Buy Mobius Imaging, Cardan Robotics for Up to $500 Million
DJ
More sector news : Medical Equipment, Supplies & Distribution - NEC
Chart T2 BIOSYSTEMS INC
Duration : Period :
T2 Biosystems Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends T2 BIOSYSTEMS INC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 3,71  $
Last Close Price 2,88  $
Spread / Highest target 108%
Spread / Average Target 28,8%
Spread / Lowest Target -30,6%
EPS Revisions
Managers
NameTitle
John P. McDonough President, Chief Executive Officer & Director
Alec Barclay Senior Vice President-Operations
John M. Sprague Chief Financial Officer
Thomas Jay Lowery Chief Scientific Officer
Michael J. Cima Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
T2 BIOSYSTEMS INC-4.32%129
MEDTRONIC PLC20.57%147 141
BAXTER INTERNATIONAL INC.32.07%44 383
HOYA CORPORATION37.15%30 886
ZIMMER BIOMET HOLDINGS33.81%28 496
TERUMO CORP-47.51%21 925